52 algorithm-phd-"Prof"-"Washington-University-in-St"-"Prof" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
and beyond. Candidate Profile We welcome applicants with diverse backgrounds in experimental or computational biology who are excited by pioneering research directions. Qualifications PhD in molecular
-
generated. Required Qualifications PhD in neuroscience, developmental biology, or related field Strong expertise in mouse neurodevelopment (mandatory) Skilled in histology, immunofluorescence, and molecular
-
to most destinations in the world. Interested candidates are encouraged to send a brief cover letter, CV and the names and contact information of 3 references to: Prithu Sundd, PhD - psundd@versiti.org
-
motivated scientist with: A PhD or MD Knowledge of Biochemistry/Molecular Biology Experience with stem cell models (required) Experience in brain analysis (desirable) About us and what we offer Located within
-
are encouraged to apply. The ideal candidate will be a PhD, MD/PhD, with experience in the general areas of immunology, molecular/cell biology and pathway analysis in experimental animals. The successful candidate
-
organoids will be plus. Dry lab: Highly motivated candidates with a PhD/MD degree in bioinformatics, genome science, systems biology, biomedical informatics, computational biology, machine learning, data
-
molecular biology and rodent models · Have experience with epigenetic techniques Your qualifications should include: · PhD in Molecular, Cellular or Developmental Biology. · Strong
-
PhD Thesis based on ABIS. The main areas have so far been studies on the development of Type 1 diabetes, but also studies on celiac disease, JIA, IBD, autism, obesity, allergy and recently also
-
has a PhD and experience in the field of cell and gene therapy for cancer and who has recent experience of primary T cell culture, CARTs, immune assays, flow cytometry, molecular cloning, retroviral